Kiran Mazumdar-Shaw Quotes

Unfortunately, our stock is somehow not well understood by the markets. The market compares us with generic companies. We need to look at Biocon as a bellwether stock. A stock that is differentiated, a stock that is focused on R&D, and a very, very strong balance sheet with huge value drivers at the end of it.
Kiran Mazumdar-Shaw
Kiran Mazumdar-Shaw

Quotes to Explore

This site uses cookies. By continuing to use this website, you agree to our policies regarding the use of cookies.